Detalhe da pesquisa
1.
High risk of infection in 'real-world' patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphoma.
Eur J Haematol
; 110(5): 540-547, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36656100
2.
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome.
Eur J Haematol
; 107(2): 181-189, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33829584
3.
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.
Ann Hematol
; 99(10): 2455-2456, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32451706
4.
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.
Leuk Lymphoma
; 62(1): 112-117, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32981406